Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell GSK plc (GSK) – GSK plc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

GSK trades at $51.61, down 1.34% on the day, with a bearish technical signal despite strong fundamentals. Recent Q1 2026 earnings beat expectations with $1.24 EPS versus $1.16 expected, driven by specialty medicines. The company maintains robust profitability with a 17.78% net margin and 36.42% ROE, while valuation metrics like P/E of 13.61 appear reasonable. Cash flow from operations remains healthy at $7.74B in 2025, though net cash flow was negative due to significant investing activities.
Outlook is mixed: solid earnings growth and dividend payments support value, but technical weakness and cautious analyst consensus (55% hold rating) suggest near-term headwinds. Key risks include pipeline execution challenges and regulatory pressures, while institutional sentiment leans neutral despite recent positive earnings momentum.
Read full analysis

Key Stats

  • Market Cap
    $102.63B
  • Sector
    Health
  • 3M Drawdown
    -15.99%
  • Enterprise Value
    $123.74B
  • Dividend Yield
    3.44%
  • Typical Hold Time
    85 days
$51.61
52W Low: $36.2
21 Jul 2025
52W High: $61.18
18 Feb 2026

GSK plc (GSK) is currently valued at a market capitalization of $102.63B, with an enterprise value of $123.74B. Over the past 52 weeks, GSK plc has traded between a low of $36.2 and a high of $61.18, highlighting its annual price range. Over the past three months, GSK plc has recorded a drawdown of -15.99%, reflecting recent price volatility. GSK plc offers a dividend yield of 3.44%, with the most recent dividend of $0.49 paid on 20 Feb 26. On average, investors hold GSK plc for approximately 85 days, indicating typical investor behavior on the platform.

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.


Technical Indicators
|
|
|
Overall Summary
Bearish (14)Neutral (11)Bullish (2)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $102.63B
  • Sector
    Health
  • 3M Drawdown
    -15.99%
  • Enterprise Value
    $123.74B
  • Dividend Yield
    3.44%
  • Typical Hold Time
    85 days
$51.61
52W Low: $36.2
21 Jul 2025
52W High: $61.18
18 Feb 2026

GSK plc (GSK) is currently valued at a market capitalization of $102.63B, with an enterprise value of $123.74B. Over the past 52 weeks, GSK plc has traded between a low of $36.2 and a high of $61.18, highlighting its annual price range. Over the past three months, GSK plc has recorded a drawdown of -15.99%, reflecting recent price volatility. GSK plc offers a dividend yield of 3.44%, with the most recent dividend of $0.49 paid on 20 Feb 26. On average, investors hold GSK plc for approximately 85 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!